ArticleAnnals of translational medicine2021

Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer.

Yusuke Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.